Navigation Links
Luminex Corporation Reports Third Quarter 2010 Results
Date:11/4/2010

y (used in) operating activities:Depreciation and amortization

2,2102,1166,4945,995Stock-based compensation

2,3192,2316,9255,817Deferred income tax benefit

985-3,4902Excess income tax benefit from employee stock-based awards

234-(1,290)-Loss on disposal of assets

---25Other

5866768491,257Changes in operating assets and liabilities:Accounts receivable, net

(1,144)(898)4,066(7,988)Inventories, net

(2,952)(286)(5,065)(1,108)Other assets

591405(154)(28)Accounts payable

1,0441,437(2,422)376Accrued liabilities

3081,295(1,037)(3,023)Deferred revenue

450(28)1,190313Net cash provided by (used in) operating activities

3,9046,33915,078(649)Cash flows from investing activities:Purchases of available-for-sale securities

(4,998)(12,003)(26,665)(56,649)Maturities of available-for-sale securities

-17,98616,19322,980Maturities of held-to-maturity securities

-3,938-40,078Purchase of property and equipment

(3,113)(3,502)(8,562)(8,618)Business acquisition consideration, net of cash acquired

--(5,036)-Increase in restricted cash

--(1,000)-Purchase of cost method investment

(76)-(2,076)-Acquired technology rights

--(1,200)(21)Net cash (used in) provided by investing activities

(8,187)6,419(28,346)(2,230)Cash flows from financing activities:Payments on debt

--(895)(440)Proceeds from debt

---454Proceeds from issuance of common stock

7771,447362Excess income tax benefit from employee stock-based awards

(234)-1,290-Net cash (used in) provided by financing activities

(227)771,842376Effect of foreign currency exchange rate on cash

(247)(246)(188)(376)Change in cash and cash equivalents

(4,757)12,589(11,614)(2,879)Cash and cash equivalents, beginning of period

83,98666,15190,84381,619Cash and cash equivalents, end of period

$ 79,229$ 78,740$ 79,229$ 78,740LUMINEX CORPORATIONRECONCI
'/>"/>

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Luminex Corporation Third Quarter Earnings Release Scheduled for November 4, 2010
2. Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna
3. Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution
4. Luminex Corporation Wins Prestigious 2010 Prix Galien USA Award
5. Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe
6. Luminex Corporation to Present at UBS Global Life Sciences Conference
7. Luminex MAGPIX System Shown to be More Cost Effective and Efficient Than Conventional ELISA Method in Initial Study
8. Luminex Announces Commercial Launch of New Cystic Fibrosis Test
9. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
10. Gentris Corporation Names New Chief Scientific Advisor
11. Unilife Corporation Schedules Fiscal 2011 First Quarter Conference Call For Monday, November 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... and Markets ( http://www.researchandmarkets.com/research/gl7m98/japan_pharma ) has announced ... Year to Watch out for Authorized Generics (AGs), Biosimilars ... The new pricing system adopted in ... 1) is a game changer initiative. It pains most ... most of the companies are revalidating their domestic (and ...
(Date:3/5/2015)... HAMPTON, N.J. , March 5, 2015 /PRNewswire/ ... ), a leading global specialty biopharmaceutical company, and Ikaria, ... they have entered into a definitive agreement under which ... a Madison Dearborn -led investor group in a ... Subject to customary closing conditions, the parties expect the ...
(Date:3/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/5sqnn3/global_rising ) has ... Outlook 2015" report to their offering. ... after with fresh vigor as new targets , approaches ... to bring a paradigm change in the way diseases ... cell therapy/Regenerative Medicine space. The number of ...
Breaking Medicine Technology:Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Global Pharma Rising Stars Outlook 2015 2
... 16, 2011 Cancer patients in China ... the announcement that a leading cancer center is acquiring ... VAR). This device is the first high dose rate ... leader in radiotherapy systems. Jilin University ...
... 16, 2011 U L ... announced today that it has filed an abbreviated 510(k) application ... label claim to include the management and mitigation of pain. ... a randomized clinical study comparing Altrazeal® to Acquacel® Ag in ...
Cached Medicine Technology:First Varian High Dose Rate Brachytherapy Afterloader Supplied to Leading China Cancer Hospital 2ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 2ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 3ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®'s Label Claim 4
(Date:3/5/2015)... East Providence, RI (PRWEB) March 05, 2015 ... for a third year in a row to support the ... cancer. The donation covered the purchase of the ‘Think ... Out’ game against Big East Conference opponent DePaul University at ... is pleased to continue our support of the PC women’s ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 In honor ... to shatter myths about drug and alcohol abuse in ... released a Fact Sheet with information on some of ... in 2010 by the National Institute on Drug Abuse, ... alcohol aims to counteract the illusions that teens and ...
(Date:3/5/2015)... 05, 2015 Califia Farms , ... the natural products coffee drinks category[1], today unveils its ... West in Anaheim, Calif. Concentrated Cold Brew (CCB) ... Café, which democratizes the next wave of the coffee-taste ... need to become their own baristas. , Califia ...
(Date:3/5/2015)... New York, NY (PRWEB) March 05, 2015 ... NY orthopedic Surgeon ( http://www.orthopedicsurgeonnyc.com ) has been named ... in the New York Metro area. Dr. Glashow has ... in its authoritative guide to the top specialty care ... 2015. , The prestigious Castle Connolly program, which carefully ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Nutrition Leaders, ... products, is pleased to offer reformulated Millennium 500 Creatine ... Millennium 500 is a German grade creatine supplement that ... promote muscle recovery, and aid with overall strength gains ... that acts as a reserve energy source in the ...
Breaking Medicine News(10 mins):Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4Health News:Dr. Jonathan Glashow, NYC Orthopedic Surgeon, Named Top Doctor: New York Metro Area 2Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2
... a study done by Kate Rittenhouse-Olson, Ph.D., the monoclonal antibody ... shown to extend// significantly the survival of mice with human ... antibody inhibits the cancer's spread to the lungs in the ... study were published in the November 2006 issue of Journal ...
... of height which happens as people catch up with age is ... which could have major repercussions on health, increasing the chances of ... of about 3 centimeters or more in height of men as ... compared to men who lose less than a centimeter. This risk ...
... Researchers from University of Queensland believe that the conotoxins ... treatment for sufferers from chronic pain//. This treatment could ... ,Researchers say that the toxin, snail uses ... the severe side effects usually caused by other pain ...
... say that they are not abandoning their quest of finding ... the death of new cholesterol drugs manufactured// by Pfizer. Reducing ... cardiology in recent years, but boosting its counterpart, HDL, also ... market the new drug with Lipitor, a cholesterol-lowering statin that ...
... will now be made more easily available to critically ill ... proposition that will enable patients// who are extremely ill to ... other options. ,The FDA has announced that they ... drugs to be made available to needy individuals .They will ...
... nosed, bleary- eyed Britons, relief from hay fever may ... pill, designed to prevent// allergic reactions like a running nose, itching ... ,The vaccine pill contains small amounts of Timothy grass pollen; main ... weeks before hay fever season. ,This pill follows the ...
Cached Medicine News:Health News:Survival of Mice With Human Breast Cancer Extended by Monoclonal Antibodies 2Health News:Revolutionary Pill Promises Relief for Hay Fever Sufferers 2
CCR Medical conventional laryngoscope handles....
... ,Developed for cardiopulmonary resuscitation and the ... Fastrach™ has been designed to facilitate blind ... The LMA Fastrach™ allows continuous ventilation between ... teams worldwide including NASA for its ease ...
Robertazzi Amber Latex Free Nasal Airways are manufactured from natural amber latex. Soft, flexible maximizing comfort....
... Available in even sizes 20-36F. Single use. ... patient comfort. The Latex-Free Robertazzi is the ... offering the best solution for latex sensitivity. ... offer a quality latex-free product as your ...
Medicine Products: